A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Acelyrin (SLRN) stock rises on an investor meeting set for Monday to discuss new Phase 2 data for lonigutamab, a drug for ...

Based on these results and the totality of data from all completed paxalisib clinical studies, Kazia requested a meeting with the FDA to discuss potential clinical and regulatory paths forward.

A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...

While generative artificial intelligence ("GenAI") has the potential to fundamentally change health care, it presents unique risks and ...

Health officials in Zamfara State have held a crucial meeting to address the ongoing challenges in the state’s drug supply ...

Kazia Therapeutics updates paxalisib's regulatory progress after FDA discussions on glioblastoma data, highlighting plans for ...

Verastem Oncology announced that the FDA has accepted for review the New Drug Application, NDA, under the accelerated approval pathway for avutometinib, an ...

Kazia Therapeutics (KZIA) provided a regulatory update on paxalisib for the treatment of glioblastoma, GBM, following its Type C clinical meeting with the United States Food and Drug ...

Verastem (VSTM) said the FDA has accepted for priority review its application for accelerated approval of its ...

Veterans have pulled in some conservative support for psychedelic therapy — managing to set it apart from other politically ...

The independent expert body tasked with making recommendations on whether new medications should receive government subsidies ...